BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28233697)

  • 1. FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.
    Huertas A; Oldrini S; Nesseler JP; Courrech F; Rétif P; Charra-Brunaud C; Peiffert D
    Cancer Radiother; 2017 Apr; 21(2):155-163. PubMed ID: 28233697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgery alone or in association with preoperative uterovaginal brachytherapy for stage IB1 cervical cancer: Toxicities profiles].
    Lamblin G; Rouffiac M; Mathevet P; Martin E; Peignaux-Casasnovas K; Chabert P; Lebail-Carval K; Chene G
    Gynecol Obstet Fertil; 2015; 43(7-8):485-90. PubMed ID: 25986397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
    Sorbe B; Bohr L; Karlsson L; Bermark B
    Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
    Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
    World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy of cervical cancer.
    Chargari C; Peignaux K; Escande A; Renard S; Lafond C; Petit A; Lam Cham Kee D; Durdux C; Haie-Méder C
    Cancer Radiother; 2022; 26(1-2):298-308. PubMed ID: 34955418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer.
    Varela Cagetti L; Gonzague-Casabianca L; Zemmour C; Lambaudie E; Houvenaeghel G; Provansal M; Sabatier R; Sabiani L; Blache G; Jauffret C; Ferré M; Mailleux H; Paciencia M; Tallet A
    Gynecol Oncol; 2021 Apr; 161(1):166-172. PubMed ID: 33563488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervix cancer brachytherapy: high dose rate.
    Miglierini P; Malhaire JP; Goasduff G; Miranda O; Pradier O
    Cancer Radiother; 2014 Oct; 18(5-6):452-7. PubMed ID: 25151650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Place of radiotherapy and surgery in the treatment of cervical cancer patients].
    Annede P; Gouy S; Haie-Meder C; Morice P; Chargari C
    Cancer Radiother; 2019 Oct; 23(6-7):737-744. PubMed ID: 31455591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
    Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
    Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What to expect from immediate salvage hysterectomy following concomitant chemoradiation and image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Bouaita R; Dumas I; Farha G; Kamsu-Kom L; Rivin Del Campo E; Martinetti F; Morice P; Haie-Meder C; Mazeron R
    Cancer Radiother; 2015 Dec; 19(8):710-7. PubMed ID: 26508320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors.
    Escande A; Gouy S; Mazeron R; Bentivegna E; Bacorro W; Maroun P; Schernberg A; Oberlander AS; Dumas I; Genestie C; Deutsch E; Morice P; Haie-Meder C; Chargari C
    Gynecol Oncol; 2017 Mar; 144(3):541-546. PubMed ID: 28095994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
    Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
    Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between conventional surgery and radiotherapy for FIGO stage I-II cervical carcinoma: a retrospective Japanese study.
    Yamashita H; Nakagawa K; Tago M; Shiraishi K; Nakamura N; Ohtomo K; Oda K; Nakagawa S; Yasugi T; Taketani Y
    Gynecol Oncol; 2005 Jun; 97(3):834-9. PubMed ID: 15894366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of high-dose-rate brachytherapy of the preoperative treatment of stage IB (FIGO) cervical carcinoma].
    Mayer A; Nemeskéri C; Póti Z
    Magy Onkol; 2004; 48(2):141-4. PubMed ID: 15351809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study.
    Aissaoui O; Phalippou J; Cordoba A; Azais H; Ouldamer L; Bolze PA; Ballester M; Huchon C; Mimoun C; Akladios C; Lecointre L; Raimond E; Graesslin O; Carcopino X; Lavoué V; Bendifallah S; Touboul C; Dabi Y; Canlorbe G; Koskas M; Chauvet P; Collinet P; Kerbage Y
    Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():128-134. PubMed ID: 37788511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
    Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
    Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.